NEUROENDOCRINE GENE REGULATION BY HOMEODOMAIN PROTEINS
同源域蛋白对神经内分泌基因的调节
基本信息
- 批准号:2876779
- 负责人:
- 金额:$ 0.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-04-15 至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Transcription factors of the homeodomain superfamily play a major
role in the development, differentiation and regulation of the nervous
system. Members of the POU class III proteins (Brn-1, -2 and -4) are
widely expressed during brain development but are restricted to specific
neuronal cell groups in the adult hypothalamus, in particular, the
magnocellular oxytocin (OT) and vasopressin (VP) expressing neurons
of the supraoptic (SON) and paraventricular (PVN) nuclei, and of the
parvocellular PVN. Ablation of the Brn-2 gene causes an inability of
developing magnocellular neurons to migrate and differentiate into
mature neurons. Consequently, homozygous Brn-2 (-/-) knockout mice
lack OT- and VP-producing neurons as well as parvocellular PVN
neurons, and have no posterior lobe of the pituitary glad.
Heterozygous (+/-) Brn-2 knockout mice have a proportional reduction
of OT and VP gene transcripts, indicating that Brn-2 expression levels
in magnocellular neurons directly control the transcription of these
neuroendocrine genes. The principal working hypothesis under
investigation is that these recently cloned homeodomain proteins
regulate OT and VP gene expression in the neuroendocrine
hypothalamus. Proposed research is focused on the following specific
aim: to determine the transcriptional action of the transfection. While
the PI has utilized some molecular techniques in his research (i.e.,
single cell quantitative in situ hybridization histochemistry, immediate
early gene mRNA induction, RNase protection assay and CNS
antisense oligonucleotide microinfusion), he would like to become
much more facile in molecular biology and its techniques in order to
creatively pursue these reproductive hormone-neuroendocrine gene
interactions at the level of gene expression. Proposed sabbatical work
in the laboratory of Dr. Peter Burbach will focus on determining the
transcriptional action of the brain homeodomain proteins (Brain-1, -2
and -4) on the oxytocin (OT) and vasopressin (VP) genes and
identifying the cis-acting elements conferring the actions of these POU
class III proteins using heterologous expression in tumor cell lines and
homologous expression in organotypical cell cultures. This work will
involve the design, construction and use of promoter-reporter gene
constructs for the 5'- and 3'-flanking regions of the OT and VP genes,
transfection by calcium-phosphate precipitation, biolistics, and or
recombinant adenoviral infection in neuronal (Neuro2A cells) and non-
neuronal tumor cell lines (293 human embryonal kidney cells, monkey
kidney CV-1 cells, BHK cells and P19 EC cells), reporter gene assays
(luciferase and beta-galactosidase), DNase I footprint analysis and
electrophoretic mobility shift assay (EMSA) utilizing COS cells and in
vitro translation. This experience should well position the PI to
subsequently pursue an innovative cellular and molecular analysis of
THE, GAD and GnRH gene regulation by these reproductive hormones
in the neuroendocrine hypothalamus. Brain homeodomain proteins
Brn-1, -2 and -4 on the OT and VP genes, and to identify the cis-acting
elements conferring the actions of these POU class III proteins using
heterologous expression in tumor cell lines and homologous expression
in organotypical cell cultures. This research will utilize promoter-
reporter gene constructs for the 5'- and 3'-flanking regions of the OT
and VP genes, transient transfection of these constructs into neuronal
and non-neuronal tumor cell lines and into organotypic cell cultures,
DNase I footprint analysis and electrophoretic mobility shift assay
(EMSA) utilizing COS cells and in vitro translation. This research will
further our understanding of the role of these POU class II
homeodomain proteins in the transcriptional regulation of OT and VP
gene expression in the neuroendocrine hypothalamus.
同源结构域超家族的转录因子起主要作用,
在神经系统发育、分化和调节中的作用
系统 POU III类蛋白的成员(Brn-1、-2和-4)是
在大脑发育过程中广泛表达,但仅限于特定的
神经元细胞群在成人下丘脑,特别是,
大细胞催产素(OT)和加压素(VP)表达神经元
视上核(SON)和室旁核(PVN),
小细胞PVN Brn-2基因的切除导致了
发育中的大细胞神经元迁移并分化成
成熟神经元 因此,纯合Brn-2(-/-)敲除小鼠
缺乏OT和VP产生神经元以及小细胞PVN
神经元,并没有垂体后叶高兴。
杂合(+/-)Brn-2敲除小鼠具有成比例的减少,
OT和VP基因转录本,表明Brn-2表达水平
在大细胞神经元直接控制这些转录
神经内分泌基因 主要工作假设
研究表明,这些最近克隆的同源结构域蛋白
调节神经内分泌中OT和VP基因的表达
下丘脑建议的研究重点是以下具体问题:
目的:确定转染的转录作用。 而
PI在其研究中使用了一些分子技术(即,
单细胞定量原位杂交组织化学
早期基因mRNA诱导、RNase保护试验和CNS
反义寡核苷酸微输注),他想成为
在分子生物学及其技术方面更加容易,
创造性地研究这些生殖器官-神经内分泌基因
基因表达水平的相互作用。 拟议休假工作
在彼得·伯巴赫博士的实验室里,
脑同源结构域蛋白(脑-1,-2
和-4)对催产素(OT)和加压素(VP)基因的影响,
鉴定赋予这些POU作用的顺式作用元件,
在肿瘤细胞系中使用异源表达的III类蛋白,
在器官型细胞培养物中同源表达。 这项工作将
涉及启动子-报告基因的设计、构建和应用
OT和VP基因的5 ′和3 ′侧翼区的构建体,
通过磷酸钙沉淀、基因枪和/或
重组腺病毒感染神经元(Neuro2A细胞)和非神经元(Non
神经元肿瘤细胞系(293个人胚肾细胞、猴胚肾细胞、人胚肾细胞)
肾CV-1细胞、BHK细胞和P19 EC细胞),报告基因测定
(荧光素酶和β-半乳糖苷酶),DNA酶I足迹分析和
利用COS细胞的电泳迁移率变动分析(EMSA),
体外翻译 这一经验应使PI能够很好地
随后进行创新细胞和分子分析,
这些生殖激素对THE、GAD和GnRH基因的调控
神经内分泌下丘脑。 脑同源结构域蛋白
Brn-1、Brn-2和Brn-4对OT和VP基因的作用,并鉴定其顺式作用
赋予这些POU III类蛋白作用的元件,
肿瘤细胞系中异源表达和同源表达
在器官型细胞培养中。 这项研究将利用启动子-
OT的5 ′-和3 ′-侧翼区的报告基因构建体
和VP基因,将这些构建体瞬时转染到神经元中,
和非神经元肿瘤细胞系以及器官型细胞培养物,
DNA酶I足迹分析和电泳迁移率变动分析
(EMSA)利用COS细胞和体外翻译。 这项研究将
进一步了解这些POU II类的作用,
同源结构域蛋白在OT和VP转录调控中的作用
下丘脑神经内分泌的基因表达。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Selmanoff其他文献
Michael Selmanoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Selmanoff', 18)}}的其他基金
NEUROENDOCRINE GENE REGULATION BY HOMEODOMAIN PROTEINS
同源域蛋白对神经内分泌基因的调节
- 批准号:
2042596 - 财政年份:1998
- 资助金额:
$ 0.03万 - 项目类别:
TUBEROINFUNDIBULAR DOPAMINE NEURONS AND PROLACTIN
结节漏斗多巴胺神经元和催乳素
- 批准号:
3074676 - 财政年份:1982
- 资助金额:
$ 0.03万 - 项目类别:
TUBEROINFUNDIBULAR DOPAMINE NEURONS AND PROLACTIN
结节漏斗多巴胺神经元和催乳素
- 批准号:
3074677 - 财政年份:1982
- 资助金额:
$ 0.03万 - 项目类别:
NEUROENDOCRINE REGULATION OF PROLACTIN SECRETION
催乳素分泌的神经内分泌调节
- 批准号:
3320231 - 财政年份:1978
- 资助金额:
$ 0.03万 - 项目类别:
NEUROENDOCRINE REGULATION OF LH AND PROLACTIN SECRETION
LH 和催乳素分泌的神经内分泌调节
- 批准号:
2888917 - 财政年份:1978
- 资助金额:
$ 0.03万 - 项目类别:
NEUROENDOCRINE REGULATION OF PROLACTIN SECRETION
催乳素分泌的神经内分泌调节
- 批准号:
3320234 - 财政年份:1978
- 资助金额:
$ 0.03万 - 项目类别:
NEUROENDOCRINE REGULATION OF LH AND PROLACTIN SECRETION
LH 和催乳素分泌的神经内分泌调节
- 批准号:
2025134 - 财政年份:1978
- 资助金额:
$ 0.03万 - 项目类别:
NEUROENDOCRINE REGULATION OF LH AND PROLACTIN SECRETION
LH 和催乳素分泌的神经内分泌调节
- 批准号:
2673522 - 财政年份:1978
- 资助金额:
$ 0.03万 - 项目类别:
NEUROENDOCRINE REGULATION OF LH AND PROLACTIN SECRETION
LH 和催乳素分泌的神经内分泌调节
- 批准号:
2198237 - 财政年份:1978
- 资助金额:
$ 0.03万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 0.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 0.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 0.03万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 0.03万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 0.03万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 0.03万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 0.03万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 0.03万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 0.03万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 0.03万 - 项目类别:
Studentship